MaaT Pharma SA (EPA:MAAT)
France · Delayed Price · Currency is EUR 2.790
+0.010 (0.36%)
Aug 3, 2026, 1:32 PM CET
MaaT Pharma Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 4.52 | 3.22 | 2.23 | 1.43 | 0.97 | |
Revenue Growth | 40.67% | 44.33% | 55.82% | 47.16% | 46.71% |
Cost of Revenue | 1.4 | 1.25 | - | 0.34 | - |
Gross Profit | 3.12 | 1.97 | 2.23 | 1.09 | 0.97 |
Selling, General & Admin | 8.22 | 6.92 | - | 4.46 | - |
Depreciation & Amortization Expenses | - | - | 0.31 | - | 0.34 |
Research & Development | 29.05 | 27.3 | - | 14.31 | - |
Other Operating Expenses | - | - | 26.14 | - | 11.2 |
Total Operating Expenses | 37.27 | 34.23 | 26.45 | 18.77 | 11.54 |
Operating Income | -29.73 | -28.43 | -22.94 | -13.56 | -10.1 |
Interest Income | 0.23 | 0.4 | 0.64 | 0.05 | 0 |
Interest Expense | 1.56 | 0.88 | -0.24 | 0.2 | -0.1 |
Other Non-Operating Income (Expense) | - | - | -0.02 | - | 0 |
Total Non-Operating Income (Expense) | 1.79 | 1.28 | 0.39 | 0.25 | -0.1 |
Pretax Income | -31.06 | -28.9 | -22.56 | -13.71 | -10.19 |
Provision for Income Taxes | - | - | -3.63 | 0 | -1.96 |
Net Income | -31.06 | -28.9 | -18.92 | -13.71 | -8.24 |
Net Income to Common | -31.06 | -28.9 | -18.92 | -13.71 | -8.24 |
Net Income Growth | - | - | - | - | - |
Shares Outstanding (Basic) | 16 | 13 | 11 | 10 | 2 |
Shares Outstanding (Diluted) | 16 | 13 | 11 | 10 | 2 |
Shares Change | 21.97% | 14.95% | 14.89% | 307.65% | 135.06% |
EPS (Basic) | -1.95 | -2.21 | -1.70 | -1.39 | -3.70 |
EPS (Diluted) | -1.95 | -2.21 | -1.70 | -1.39 | -3.70 |
EPS Growth | - | - | - | - | - |
Additional Metrics
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -16.33 | -22.79 | -19.76 | -13.27 | -8.17 |
Free Cash Flow Growth | - | - | - | - | - |
Free Cash Flow Per Share | -1.02 | -1.74 | -1.74 | -1.34 | -3.37 |
Gross Margin | 69.05% | 61.13% | 100.00% | 76.29% | 100.00% |
Operating Margin | -657.14% | -883.95% | -1029.70% | -948.04% | -1039.05% |
Profit Margin | -686.58% | -898.76% | -849.25% | -958.95% | -847.57% |
FCF Margin | -360.88% | -708.77% | -886.92% | -927.76% | -840.46% |
EBITDA | -27.99 | -26.74 | -22.07 | -13.13 | -9.77 |
EBITDA Margin | -618.79% | -831.34% | -990.61% | -918.04% | -1005.30% |
EBIT | -29.73 | -28.43 | -22.94 | -13.56 | -10.1 |
EBIT Margin | -657.14% | -883.95% | -1029.70% | -948.04% | -1039.05% |
Effective Tax Rate | 0.00% | 0.00% | 16.11% | 0.00% | 19.19% |